Portfolio company
Atley Solutions
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company manufactures automated systems and radiochemical supplies for pharmaceutical developers to produce astatine-211 cancer therapies.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AtomVie Global Radiopharma Inc.
The company develops and manufactures radiopharmaceuticals for pharmaceutical and biotechnology organisations involved in clinical trials and commercial supply.
Actithera
This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.
Astral Systems
The company develops compact nuclear fusion reactors for healthcare providers and researchers to produce medical radioisotopes for cancer diagnosis and treatment.
Full-Life Technologies
This company develops radiopharmaceuticals and radionuclide drug conjugates to treat cancer patients through targeted alpha therapy.
AtomVie
The company manufactures and distributes radiopharmaceutical drugs for clinical and commercial use by biotechnology and pharmaceutical organisations.
Actithera Group
This company develops radioligand therapies to treat cancer patients by delivering radiation directly to solid tumours while sparing healthy tissue.
Alpha-9 Theranostics
This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.
Rocket Isotopes AG
The company produces medical radioisotopes for pharmaceutical firms and clinical trials to facilitate radioligand therapies for cancer patients.